Lung Cancer Surgery: Essential Patient Insights

Lung Cancer Surgery: What Patients Need to Know

Lung Cancer Surgery: What Patients Need to Know. Lung cancer surgery can be curative for some people—particularly when non-small cell lung cancer (NSCLC) is diagnosed before it has spread widely. But “lung cancer surgery” is not one operation. The amount of lung removed, the surgical approach, the need to remove lymph nodes, and whether surgery should be combined with chemotherapy, immunotherapy, targeted therapy, or radiation all depend on the individual cancer.

This guide explains what patients should know when they’ve been diagnosed with lung cancer but before agreeing to lung cancer surgery.

Important: This article is educational and is not a substitute for medical advice. The appropriate operation depends on your cancer type, stage, tumor location, lung function, overall health, and the expertise of your multidisciplinary cancer team.

I am a long-term survivor of an incurable blood cancer called multiple myeloma.

Though my cancer is different from lung cancer, surgery was instrumental to my original diagnosis and therapies. I wish I knew then what I know now.

My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about surgery for melanoma.

Good luck,

David Emerson

Understanding Prehabilitation for Lung Cancer Surgery

Concepts Central to Managing Your Cancer-

Possible Therapies-

Key Takeaways

Surgery is most commonly used with curative intent for early-stage and selected locally advanced non-small cell lung cancers.
The operation may remove a small portion of a lung, an entire lobe, or—less commonly—an entire lung.
Lobectomy is no longer automatically the only appropriate operation for every small early-stage lung cancer. Modern randomized trials support lung-sparing surgery for carefully selected tumors.
Lymph-node evaluation is a critical part of lung cancer surgery because lymph-node involvement can change the cancer stage and the need for additional treatment.
Minimally invasive approaches such as VATS (video-assisted thoracoscopic surgery) and robotic surgery are increasingly used.
Surgery may be performed before or after systemic treatment, depending on stage and tumor biology.
Recovery involves more than healing the incision. Breathing exercises, walking, pain control, nutrition, and pulmonary rehabilitation can all matter.
Patients should ask not only, “Can you remove my tumor?” but also, “What operation gives me the best balance between cancer control and preservation of lung function?”

What Is Lung Cancer Surgery?

Lung cancer surgery is an operation designed to remove the cancer along with an appropriate margin of surrounding tissue.

For patients with potentially resectable NSCLC, surgery may offer the possibility of long-term disease control or cure. The National Cancer Institute notes that resectable NSCLC is generally concentrated in stage I, stage II, and selected stage III disease.

However, surgery is not automatically appropriate simply because a tumor is technically removable.

Your medical team must consider:

Cancer type
Tumor size
Tumor location
Cancer stage
Lymph-node involvement
Whether the cancer has spread elsewhere
Lung function
Heart function
Other medical conditions
Smoking history
Previous cancer treatments
Your ability to tolerate anesthesia and surgery
Your personal treatment goals

This is one reason a multidisciplinary lung cancer team can be valuable.

What Type of Lung Cancer Is Being Treated?

The distinction between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) is extremely important.

NSCLC includes several major subtypes, including:

Adenocarcinoma
Squamous cell carcinoma
Large-cell and other less-common NSCLC subtypes

Surgery plays a much smaller role in small cell lung cancer because SCLC has a greater tendency to spread early. The NCI notes that localized surgery rarely produces long-term survival by itself in SCLC.

Therefore, when someone asks, “Can lung cancer be cured with surgery?”, the answer depends heavily on the type and stage of lung cancer.

When Is Lung Cancer Surgery Considered?

Surgery is most commonly considered when the cancer is confined to the lung or nearby structures and can be completely removed.

For example, treatment of stage I NSCLC may include:

Wedge resection
Segmental resection
Lobectomy
Sleeve resection

For selected stage II and stage IIIA cancers, surgery may also be part of a larger treatment plan involving chemotherapy, immunotherapy, targeted therapy, or radiation.

The important point is that stage alone does not determine whether surgery is appropriate.

Two people with the same stage may have very different treatment plans because their tumors differ in location, molecular characteristics, lymph-node involvement, or their ability to tolerate surgery.

The Four Major Types of Lung Cancer Resection

1. Wedge Resection

A wedge resection removes the tumor along with a wedge-shaped portion of surrounding healthy lung tissue.

It removes less lung than a lobectomy.

Wedge resection may be considered when:

The tumor is small and peripheral
The cancer is appropriately staged
Preserving lung tissue is particularly important
A patient cannot tolerate a larger operation
The tumor’s location makes wedge resection appropriate

Wedge resection is also sometimes used for diagnosis or for selected patients with very early disease.

2. Segmentectomy

A segmentectomy removes an anatomical segment of a lung rather than the entire lobe.

This is more extensive than a wedge resection but preserves more lung than a lobectomy.

This distinction has become increasingly important.

Historically, lobectomy was generally considered the standard operation for early-stage NSCLC. But modern randomized trials have changed the discussion.

The JCOG0802/WJOG4607L randomized trial found that anatomical segmentectomy was not inferior to lobectomy for appropriately selected small peripheral NSCLC and produced better overall survival in that study population.

The CALGB/Alliance 140503 trial likewise found that, among patients with peripheral NSCLC measuring 2 cm or less and pathologically confirmed node-negative disease, sublobar resection was not inferior to lobectomy for disease-free survival, with similar overall survival.

What does this mean for patients?

It does not mean:

“Everyone with a small lung tumor should have a segmentectomy.”

Instead, it means that some carefully selected patients may be able to have less lung removed without sacrificing cancer outcomes.

Tumor location, size, margins, lymph-node status, tumor biology, and surgical expertise all matter.

3. Lobectomy

A lobectomy removes an entire lobe of the lung.

The right lung contains three lobes:

Upper
Middle
Lower

The left lung contains two:

Upper
Lower

For many patients with localized NSCLC, lobectomy remains an important surgical option.

The operation removes more lung than wedge resection or segmentectomy but can provide a wider anatomical resection.

The question is no longer simply:

“Is lobectomy the standard?”

A better question may be:

“For this particular tumor, does lobectomy provide an important cancer-control advantage over a lung-sparing operation?”

That is a discussion worth having with your thoracic surgeon.

4. Pneumonectomy

A pneumonectomy removes an entire lung.

It is a much larger operation and is generally reserved for tumors that cannot be completely removed with a smaller resection.

Because an entire lung is removed, the effect on breathing capacity can be substantial.

If pneumonectomy is being recommended, patients should consider obtaining a second opinion from an experienced thoracic oncology center.

What Is a Sleeve Resection?

A sleeve resection removes a portion of the airway along with the tumor and reconnects the remaining airway.

The goal is sometimes to remove the cancer while preserving the lung.
This can be particularly important when a tumor involves a major bronchus.
The NCI recognizes sleeve resection as one of the surgical approaches used for NSCLC.

Open Surgery vs. Minimally Invasive Surgery

There are two broad ways surgeons access the chest.

Thoracotomy

A thoracotomy involves a larger incision between the ribs.

It may be necessary for certain tumors or complicated operations.

VATS

Video-assisted thoracoscopic surgery (VATS) uses several smaller incisions and a camera to perform the operation.

Robotic Surgery

Robotic-assisted thoracic surgery uses specialized instruments controlled by the surgeon through a robotic platform.

The American Lung Association describes VATS and robotic surgery as minimally invasive approaches that can use several small incisions rather than the larger incision associated with thoracotomy.

Which approach is better?

There isn’t one answer for every patient.

Ask:

“Am I a candidate for minimally invasive surgery, and if not, why not?”

The location and complexity of the tumor matter. So does the surgeon’s experience.

Why Are Lymph Nodes Removed During Lung Cancer Surgery?

This is one of the most important—and sometimes overlooked—parts of lung cancer surgery.

Cancer cells can travel from the primary lung tumor to nearby lymph nodes.

Lymph-node examination can therefore determine whether cancer has spread beyond the original tumor.

This information helps establish the cancer’s TNM stage and can influence whether additional treatment is recommended.

The NCI emphasizes that pathological staging after lung cancer resection requires assessment of the tumor, surgical margins, and lymph-node status.

Research has also found that the number of lymph nodes examined is associated with more accurate staging.

A question worth asking your surgeon:

“How will you evaluate my mediastinal and hilar lymph nodes during surgery?”

For patients with suspicious mediastinal lymph nodes before surgery, procedures such as EBUS or EUS-guided needle sampling may be used to obtain tissue and establish whether cancer has spread. Current European multidisciplinary guidance continues to emphasize accurate mediastinal staging before treatment.

What Happens Before Lung Cancer Surgery?

The preoperative evaluation may include:

Imaging

Depending on the situation, testing may include:

Chest CT
PET/CT
Brain imaging
Other imaging needed for staging

Tissue Diagnosis

A biopsy may establish the type of lung cancer.

Pulmonary Function Testing

Your physicians need to know how well your lungs work before removing lung tissue.

Heart Evaluation

Some patients require cardiac evaluation before surgery.

Functional Assessment

Your overall fitness and ability to tolerate surgery matter.

Molecular Testing

For many NSCLC patients, molecular and biomarker testing can influence the overall treatment plan.

Should You Have a Second Opinion Before Lung Cancer Surgery?

For many patients, a second opinion is reasonable.

This is especially true if:

A pneumonectomy has been recommended
The tumor is borderline resectable
Stage III disease is involved
You have significant lung disease
You have significant heart disease
You are being offered a major open operation
You are uncertain whether a lung-sparing operation is possible
Your treatment plan involves several different therapies

The NCI specifically notes that some people with NSCLC seek a second opinion and may have their pathology, scans, or treatment plan reviewed by another specialist.

A second opinion is not necessarily a rejection of your first surgeon.

It can simply help you understand your choices.

What Happens During Lung Cancer Surgery?

Although every operation is different, a typical resection may involve:

General anesthesia
Placement of breathing equipment
Access to the chest
Identification of the tumor
Removal of the planned portion of lung
Removal or sampling of appropriate lymph nodes
Examination of surgical margins
Placement of one or more chest tubes
Closure of the incisions

The removed tissue is sent to pathology.

That pathology report becomes extremely important.

Why Surgical Margins Matter

A surgical margin is the edge of tissue removed around the tumor.

Ideally, the surgeon removes the tumor with an adequate margin of cancer-free tissue.

The pathology report will help determine whether the cancer appears to have been completely removed.

Ask:

“Were my surgical margins negative?”

And:

“How wide was the margin compared with the tumor?”

The answer can influence decisions about additional treatment and surveillance.

What Happens After Lung Cancer Surgery?

Immediately after surgery, patients may experience:

Pain
Fatigue
Shortness of breath
Coughing
Difficulty sleeping
Reduced appetite
Chest discomfort
Limited mobility

A chest tube is commonly used to drain air and fluid from the chest and may remain in place for several days. Some patients may even go home temporarily with a chest tube.

Pain management is important because uncontrolled pain can make it difficult to breathe deeply and move around.

Breathing Exercises Matter

After lung surgery, your healthcare team may encourage:

Deep-breathing exercises
Incentive spirometry
Coughing exercises
Early walking
Respiratory therapy

These measures are intended to help restore lung function and reduce postoperative complications.

Enhanced Recovery After Surgery (ERAS) recommendations for thoracic surgery emphasize a coordinated approach to perioperative care designed to reduce complications and facilitate recovery.

How Long Does Recovery Take?

Recovery varies substantially.

A minimally invasive operation may allow a faster recovery than a major open operation, but there is no universal timeline.

Recovery depends on:

Type of surgery
Amount of lung removed
Surgical approach
Age
Baseline lung function
Smoking history
Other medical conditions
Complications
Whether chemotherapy or immunotherapy is needed afterward

It is important not to judge your recovery against another patient’s.

Possible Complications of Lung Cancer Surgery

Lung surgery is major surgery.

Potential complications include:

Prolonged air leak
Pneumonia
Atelectasis
Infection
Bleeding
Blood clots
Heart rhythm abnormalities
Respiratory problems
Need for prolonged chest-tube drainage
Need for additional procedures
Rarely, death

Prolonged air leak is one of the recognized complications following lung resection and can extend chest-tube duration and hospitalization.

Postoperative pulmonary complications such as pneumonia, atelectasis, and empyema remain important concerns following lung resection.

Atrial fibrillation is another potential complication after lung cancer surgery.

Don’t ignore new symptoms after surgery.

Contact your surgical team promptly if you develop symptoms such as:

Increasing shortness of breath
Fever
Worsening chest pain
Increasing redness or drainage from the incision
Persistent rapid heartbeat
Confusion
Severe weakness
Sudden leg swelling
Coughing up significant blood

Your surgical team should provide specific instructions for when to call and when to seek emergency care.

What Happens to Your Lung Capacity After Surgery?

This is one of the most important questions to discuss before surgery.

Removing lung tissue can reduce pulmonary function.

But the amount of functional loss varies.

A person undergoing a wedge resection will generally have a different postoperative pulmonary reserve than someone undergoing pneumonectomy.

This is one reason lung-sparing surgery can be particularly important for selected patients.

The CALGB 140503 trial found a small advantage in predicted FEV1 at six months for patients undergoing sublobar rather than lobar resection, while cancer outcomes were similar in the carefully selected trial population.

What If I Have COPD or Poor Lung Function?

Poor lung function does not automatically mean that surgery is impossible.

Your team may evaluate:

FEV1
Diffusing capacity
Exercise capacity
Oxygen levels
Cardiac function
Predicted postoperative lung function

Some patients with limited pulmonary reserve may be better candidates for a smaller resection or for a nonsurgical treatment such as stereotactic body radiation therapy (SBRT).

The goal is not simply to remove the tumor.

The goal is to treat the cancer without leaving the patient with unacceptable loss of lung function.

Will I Need Chemotherapy After Surgery?

Possibly.

Surgery removes visible and surgically accessible cancer, but microscopic cancer cells may remain elsewhere in the body.

Depending on the stage and biology of the cancer, postoperative treatment may include:

The NCI lists multiple postoperative treatment strategies for selected stage II and III NSCLC patients.

The pathology report after surgery can therefore be the beginning—not the end—of treatment planning.

What About Immunotherapy Before or After Surgery?

The treatment of resectable NSCLC has changed significantly.

Some patients receive systemic therapy before surgery, sometimes including chemotherapy plus immunotherapy.

Other patients may receive postoperative systemic treatment.

The appropriate strategy depends on stage, molecular characteristics, PD-L1 status, tumor biology, and other factors.

This is another reason not to think about surgery in isolation.

Modern lung cancer treatment is increasingly a sequence of treatments rather than a single treatment.

Can Radiation Replace Lung Cancer Surgery?

Sometimes.

For patients who cannot safely undergo surgery, stereotactic body radiation therapy (SBRT) may be an important treatment option for selected early-stage NSCLC.

The NCI lists external radiation, including SBRT, as an option for some patients who cannot undergo surgery or choose not to have surgery.

That does not mean surgery and SBRT are interchangeable for every patient.

The appropriate choice depends on:

Tumor size
Tumor location
Stage
Lung function
Other medical conditions
Surgical risk
Patient preferences

A Particularly Important Question: “How Much Lung Do I Really Need to Lose?”

If you are being offered a lobectomy, consider asking:

“Would a segmentectomy or wedge resection be oncologically appropriate in my case?”

And:

“What would I gain—and what might I lose—by choosing the larger operation?”

The answer should be based on your specific tumor.

Recent randomized evidence has expanded the role of sublobar resection for carefully selected peripheral tumors measuring 2 cm or less with no involved hilar or mediastinal lymph nodes.

Questions to Ask Your Thoracic Surgeon

Before surgery, consider bringing this list to your appointment.

About the cancer

What type of lung cancer do I have?
What is my clinical stage?
Has my cancer spread to any lymph nodes?
Has molecular testing been completed?
What is the goal of surgery?

About the operation

Which operation do you recommend?
Why is this operation better than a smaller resection?
Could I have a segmentectomy?
Could I have a wedge resection?
Would minimally invasive surgery be appropriate?
Would you use VATS or robotic surgery?
Under what circumstances would you convert to open surgery?
How many lung cancer operations do you perform each year?

About lymph nodes

Which lymph nodes will be removed or sampled?
How will my mediastinal lymph nodes be evaluated?
How many lymph nodes do you expect to examine?

About recovery

How long will I probably remain hospitalized?
How long might I have a chest tube?
When can I walk normally?
When can I drive?
When can I exercise?
Will I need pulmonary rehabilitation?

About treatment after surgery

Will I need chemotherapy?
Will I need immunotherapy?
Will I need targeted therapy?
Will I need radiation?
How soon after surgery will we know whether additional treatment is necessary?

Lung Cancer Surgery and the “Second Opinion” Question

One of the most valuable things a lung cancer patient can do before major surgery is understand why that particular operation is being recommended.

If your surgeon recommends removing an entire lobe, ask why.
If your surgeon recommends a segmentectomy, ask why.
If your surgeon recommends pneumonectomy, ask whether another surgical approach could preserve the lung.

And if surgery is not recommended, ask:

“What specifically makes my cancer unresectable?”

Those answers can help you understand the difference between:

“The tumor cannot be removed.”

and

“The tumor can be removed, but surgery isn’t the best treatment for me.”

Those are very different statements.

PeopleBeatingCancer’s Perspective

At PeopleBeatingCancer, we believe cancer patients should understand the why behind their treatment decisions.

Lung cancer surgery is a particularly good example.

The objective should not simply be:

Remove as much cancer as possible.

It should be:

Achieve the best possible cancer control while preserving as much healthy lung function and quality of life as reasonably possible.

That means asking about the tumor’s biology, its location, its stage, lymph-node status, surgical margins, the amount of lung that will be removed, and the treatments that may follow.

It also means understanding when surgery is not the best option.

A good treatment decision is an informed decision.

PeopleBeatingCancer Evidence Rating

Evidence Rating: Strong

There is strong clinical evidence supporting surgical resection for appropriately selected patients with resectable NSCLC.

There is also high-level randomized evidence supporting sublobar resection as an appropriate option for carefully selected patients with small, peripheral, node-negative NSCLC.

However, the evidence should not be interpreted as saying that one operation is best for every patient.

The most appropriate operation remains dependent on tumor characteristics, staging, pulmonary reserve, overall health, and surgical expertise.

Research and Evidence

The following are useful starting points for patients, caregivers, and clinicians.

National Cancer Institute

Non-Small Cell Lung Cancer Treatment (PDQ®)
The NCI’s continually updated overview of NSCLC treatment, staging, surgery, radiation, chemotherapy, immunotherapy, and targeted therapy.

NCI: Non-Small Cell Lung Cancer Treatment

JCOG0802/WJOG4607L

Randomized phase III trial comparing segmentectomy with lobectomy for small peripheral NSCLC.

PubMed: Segmentectomy versus Lobectomy

CALGB/Alliance 140503

Randomized trial comparing sublobar and lobar resection for peripheral stage IA NSCLC.

PubMed: Lobar or Sublobar Resection for Peripheral Stage IA NSCLC

2026 Review of CALGB 140503

A 2026 review discusses how randomized evidence has shifted surgical practice toward lung-sparing approaches for selected small peripheral node-negative NSCLC.

PubMed: CALGB 140503 and the Shift to Sublobar Resection

Mediastinal Lymph-Node Staging

Accurate lymph-node staging is critical when determining treatment for potentially resectable NSCLC.

PubMed: Revised ESTS Guidelines for Mediastinal Lymph-Node Staging

Enhanced Recovery After Lung Surgery

ERAS/ESTS recommendations address evidence-based strategies for improving recovery after thoracic surgery.

PubMed: ERAS Guidelines for Lung Surgery

Postoperative Air Leaks

Prolonged air leak is an important complication following lung resection and can extend chest-tube duration and hospitalization.

PubMed: Management of Prolonged Air Leak After Lung Surgery

Frequently Asked Questions

Is lung cancer surgery curative?

It can be. Surgery may be potentially curative for appropriately selected patients with localized or locally advanced NSCLC. However, the risk of recurrence depends on stage, lymph-node involvement, tumor biology, margins, and other factors.

Is a lobectomy always necessary for lung cancer?

No. For carefully selected patients with small peripheral node-negative NSCLC, randomized trials have demonstrated that sublobar resection can provide outcomes comparable to lobectomy.

Is robotic lung cancer surgery better?

Robotic surgery is one form of minimally invasive surgery. Whether it is appropriate depends on the tumor and surgeon. The important question is whether the operation can achieve an appropriate cancer resection safely.

How much lung can be removed?

Depending on the tumor, surgery may remove a wedge, a segment, a lobe, or an entire lung.

How long does it take to recover from lung cancer surgery?

Recovery varies considerably. Minimally invasive surgery may shorten recovery for some patients, but the amount of lung removed, complications, baseline health, and subsequent treatment all influence recovery.

Can lung cancer come back after surgery?

Yes. Surgery removes known disease but does not guarantee that microscopic cancer cells are absent elsewhere. This is why postoperative pathology, surveillance, and—when appropriate—additional systemic treatment are important.

Should I get a second opinion?

For a major operation, especially pneumonectomy or surgery for stage III disease, a second opinion from an experienced thoracic oncology center can be reasonable.

Final Thought

Lung cancer surgery has changed.

For decades, the discussion often centered on whether a patient could tolerate a lobectomy.

Today, the conversation can be more nuanced:

What is the smallest operation that can safely and effectively treat this particular cancer?

For some patients, that may still be a lobectomy.

For others, modern evidence supports considering a segmentectomy or another sublobar operation.

And for some patients, surgery may not be the best treatment at all.

The most important thing is to understand your tumor, your stage, your surgical options, and the treatment plan surrounding the operation before you enter the operating room.

Our Mission